The Quantellect read.As of Nov 19, 2026, 5 active firms cover Biomea Fusion Inc: 5 rate it Buy or better, 0 sit at Neutral, and 0 rate it Sell or worse, a buy consensus. The target range is very wide, $4.00 to $12.00 (about 3.0x), which points to deep disagreement over how to value the company rather than near-term timing. The average target of $8.00 sits 1423% above the current $0.53. The rating mix has stayed broadly stable, with Buy-side ratings edging up from 3 to 5 over recent months. On the fundamentals, the Street sees revenue growth near 0% this year and 0% next, consensus EPS building from about $-0.12 next quarter toward $-0.85 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS5 active firms
Buy
Strong Buy00%
Buy5100%
Neutral00%
Sell00%
Strong Sell00%
Based on 5 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$8.00
+1422.9% upside
Average target across 5 active firms as of Nov 19, 2026 vs $0.53 current
Highest Target$12.00
Average Target$8.00
Lowest Target$4.00
Detailed analyst forecasts for BMEA
Showing 1–5 of 5 named analysts shown · 5 active firms in the rating projection
As of Nov 19, 2026, 5 of 5 active firms rate BMEA a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
BMEA EPS & revenue forecast
EPS · NEXT QUARTER
$-0.12
Range $-0.12 – $-0.12 · 1 analysts · -30% YoY
Next period, 1 analysts expect Biomea Fusion Inc to earn $-0.12 a share (range $-0.12 – $-0.12), versus $-0.17 a year earlier. Full-year consensus is $-0.63, growing to $-0.85 the year after.
REVENUE · NEXT QUARTER
$0
Range $0 – $0 · 1 analysts · +0% YoY
Revenue is expected to reach $0 (range $0 – $0), +0.0% year-over-year. Full-year consensus is $0, rising to $0 next year.
Top analysts covering Biomea Fusion Inc
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on BMEA.
#1
Jonathan Wolleben
JMP Securities · Rank #54
Buy
$7.00+1232.6% to target
Overall win rate
43%
+ Follow
#2
Peter Lawson
Barclays · Rank #89
Neutral
$3.00+471.1% to target
Overall win rate
45%
+ Follow
#3
Roger Song
Jefferies · Rank #122
Buy
$5.00+851.8% to target
Overall win rate
43%
+ Follow
#4
Anupam Rama
JP Morgan · Rank #171
Sell
No targeton BMEA
Overall win rate
48%
+ Follow
#5
George Farmer
Scotiabank · Rank #311
Buy
$10.00+1803.7% to target
Overall win rate
44%
+ Follow
BMEA stock forecast FAQ
What is BMEA's average 12-month price target?+
The 5 active firms with a live target average $8.00 for Biomea Fusion Inc over the next 12 months, ranging from a $12.00 high to a $4.00 low, as of Nov 19, 2026.
Is BMEA stock a Buy, Sell or Neutral right now?+
The current consensus is Buy. Of the 5 active firms as of Nov 19, 2026, 5 rate it Buy or Strong Buy, 0 rate it Neutral, and 0 rate it Sell or Strong Sell.
What are the highest and lowest price targets for BMEA?+
The Street-high target is $12.00 (D. Boral Capital), and the Street-low is $4.00 (HC Wainwright & Co.). The average of all 5 active-firm targets is $8.00.
How many active Wall Street firms cover BMEA?+
5 active firms have a recognized rating on Biomea Fusion Inc as of Nov 19, 2026, and 5 active firms carry a live 12-month price target.
Who is the most accurate analyst covering BMEA?+
Among analysts who currently cover BMEA, Jonathan Wolleben of JMP Securities has the strongest overall Quantellect track record (Rank #54). Their current call is Buy with a $7.00 target.
What is Biomea Fusion Inc's projected EPS for next quarter?+
The consensus estimate is $-0.12 per share (range $-0.12 – $-0.12) across 1 analysts. Full-year EPS is projected at $-0.63, rising to $-0.85 the following year.
How much revenue is Biomea Fusion Inc expected to report next quarter?+
Consensus revenue is $0 (range $0 – $0). Full-year revenue is projected at $0, growing to $0 next year.
Have analysts been upgrading or downgrading BMEA lately?+
As of Nov 19, 2026, 5 of 5 active firms rate BMEA a Buy (0 Neutral, 0 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their BMEA calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.